Delving into the Latest Updates on Apollo Therapeutics Group Ltd. with Synapse

A Phase 1b, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Camoteskimab in Subjects With Adult Onset Still's Disease

The main purpose of the study is to evaluate the safety and tolerability of Camoteskimab in participants with Still's Disease.

开始日期2021-03-25

申办/合作机构

Apollo Therapeutics Group Ltd.

100 项与 Apollo Therapeutics Group Ltd. 相关的临床结果

登录后查看更多信息

0 项与 Apollo Therapeutics Group Ltd. 相关的专利（医药）

登录后查看更多信息

2

项与 Apollo Therapeutics Group Ltd. 相关的文献（医药）

2024-05-01·C108. MECHANISMS OF LUNG INFLAMMATION AND INFECTION

A Rhinovirus VP0 Vaccine Induces Cross-reactive Type 1 Immunity and Promotes Lymphocyte Activation and Maturation

作者: Edwards, M.R. ; Shaw, S. ; Johnston, S.L. ; Patel, N.D. ; Pyle, C.J.

2023-05-01·D13. INNATE AND ADAPTIVE IMMUNE MECHANISMS REGULATING LUNG DISEASE

A Rhinovirus-A16 VP0 Vaccine Induces Homotypic Humoral and Cellular Immunity, and Following Heterotypic Rhinovirus-A01 Infection, Accelerates Virus Clearance and Induces Cross-strain IFN-γ T Cell and Neutralising Antibody Responses